PSP
AZN icon

Principal Street Partners’s AstraZeneca AZN Stock Holding History

Principal Street Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$933K Hold
4,923
– – 0.14% 98
2026
Q1 		$971K Sell
4,923
-1
-0% -$193 0.16% 80
2025
Q4 		$905K Sell
4,924
-487
-9% -$85.4K 0.15% 81
2025
Q3 		$830K Sell
5,411
-10,141
-65% -$1.53M 0.13% 93
2025
Q2 		$2.17M Buy
15,552
+10,454
+205% +$1.47M 0.21% 72
2025
Q1 		$749K Buy
5,098
+641
+14% +$92.7K 0.14% 91
2024
Q4 		$584K Sell
4,457
-4,610
-51% -$645K 0.11% 114
2024
Q3 		$1.41M Buy
9,067
+4,493
+98% +$725K 0.23% 70
2024
Q2 		$713K Hold
4,574
– – 0.13% 93
2024
Q1 		$705K Buy
4,574
+223
+5% +$29.5K 0.13% 103
2023
Q4 		$586K Sell
4,351
-4,684
-52% -$609K 0.14% 101
2023
Q3 		$1.22M Buy
9,035
+4,644
+106% +$634K 0.24% 74
2023
Q2 		$629K Buy
4,391
+34
+0.8% +$5K 0.15% 97
2023
Q1 		$605K Sell
4,357
-159
-4% -$21.4K 0.15% 98
2022
Q4 		$612K Sell
4,516
-357
-7% -$44.8K 0.15% 99
2022
Q3 		$534K Sell
4,873
-136
-3% -$17.3K 0.14% 118
2022
Q2 		$662K Buy
5,009
+140
+3% +$18.4K 0.17% 94
2022
Q1 		$646K Buy
+4,869
New +$584K 0.15% 118
2021
Q4 		– Sell
-4,491
Closed -$539K – 196
2021
Q3 		$539K Buy
4,491
+1,322
+42% +$154K 0.15% 114
2021
Q2 		$380K Buy
3,169
+218
+7% +$23.9K 0.1% 149
2021
Q1 		$293K Buy
2,951
+23
+0.8% +$2.31K 0.04% 174
2020
Q4 		$293K Hold
2,928
– – 0.09% 148
2020
Q3 		$321K Buy
+2,928
New +$326K 0.11% 119
2020
Q2 		– Sell
-4,074
Closed -$364K – 129
2020
Q1 		$364K Hold
4,074
– – 0.15% 100
2019
Q4 		$406K Hold
4,074
– – 0.09% 147
2019
Q3 		$363K Buy
4,074
+18
+0.4% +$1.56K 0.09% 146
2019
Q2 		$335K Buy
+4,056
New +$318K 0.18% 118

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Principal Street Partners's AZN Position: Q2 2026 in Review

Principal Street Partners held its AstraZeneca (AZN) position steady in Q2 2026 at 4,923 shares worth $933K. The position accounts for 0.14% of the portfolio, ranked #98.

Principal Street Partners first reported a position in AZN in Q2 2019 and has held it in 27 quarters since. The position peaked at $2.17M in Q2 2025. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Principal Street Partners held 4,923 shares of AstraZeneca worth $933K as of Q2 2026.
  • Principal Street Partners left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.14% of Principal Street Partners's portfolio in Q2 2026, its #98 holding.
  • Principal Street Partners first reported a position in AstraZeneca in Q2 2019 and has held it in 27 quarters since.
  • Principal Street Partners's AstraZeneca position peaked at $2.17M in Q2 2025.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Principal Street Partners's 13F filing for Q2 2026, filed 14 Aug 2026.